BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments January 19, 2023
BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP™ Technology January 10, 2023
Update: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore December 14, 2022
BioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology December 6, 2022
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology October 24, 2022
